Multiple sclerosis Trials in Fairfield, United States
Conditions / Multiple sclerosis / Fairfield, United States
Research into Multiple sclerosis spans multiple therapeutic approaches and trial phases.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01457924 | Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis | COMPLETED | PHASE2 |
| NCT00340834 | Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase | COMPLETED | PHASE3 |
| NCT03436199 | Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment | COMPLETED | PHASE3 |
| NCT02410278 | Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera | COMPLETED | PHASE4 |
| NCT00355134 | Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis | COMPLETED | PHASE3 |
| NCT03567057 | A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment | COMPLETED | PHASE3 |
| NCT02807285 | Expanded Access Program for Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis | NO_LONGER_AVAILABLE | — |
| NCT03933202 | A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2) | COMPLETED | — |
| NCT01442194 | Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies | COMPLETED | — |
| NCT00751881 | An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis | COMPLETED | PHASE3 |